News

Five UCL academics have received prestigious European Union-funded grants to support research for the next five years in projects covering economics, criminal governance, and neuroscience.

An AI tool that can analyse abnormalities in the shape and form of blood cells, and with greater accuracy and reliability than human experts, could change the way conditions such as leukaemia are diagnosed, finds a study co-led by a UCL academic.

Professor Sarah Tabrizi, Director of the UCL Huntington’s Disease Centre, has been awarded the British Neuroscience Association (BNA) Outstanding Contribution to Neuroscience Award for 2025, the association’s top annual prize.

Professor Sarah Tabrizi (UCL Queen Square Institute of Neurology) has been named in Nature's 10 list, recognising the people involved in the most influential and important developments this year.

The latest Neuromuscular Diseases (NMD) Research Day took place in November 2025, bringing together clinicians, researchers, and partners to strengthen the future of NMD research.

The collaboration is tasked with gaining a better understanding of and validating the mechanisms involved in Developmental and Epileptic Encephalopathy (DEE).